Back to Pharma Services
Legal / Service Provider·Pharma Services

Jeanna Palmer Gunville

Healthcare Transactions and Regulatory Partner at Morgan Lewis

Chicago, IL

JP
LinkedIn
Why they matter

A Chicago healthcare regulatory dealmaker who structures PE-backed provider platform deals and can flag Stark/AKS risk before it kills a transaction.

Background

Jeanna Palmer Gunville is a healthcare transactions and regulatory partner who joined Morgan Lewis's Chicago office in July 2025 after several years as a shareholder at Polsinelli. She advises hospitals, health systems, academic medical centers, post-acute care providers, and private equity-backed healthcare businesses on M&A, joint ventures, clinical integration, and regulatory compliance (Stark/Anti-Kickback). She holds a J.D. from Loyola University Chicago School of Law (2007) and a B.A. from the University of Notre Dame (2003), and previously clerked in the Illinois Attorney General's Health Care Bureau.

Notable deals

  • 2025
    Joined Morgan Lewis as healthcare transactions and regulatory partner in Chicago, lateraling from Polsinelli
  • 2024
    Featured speaker on AHLA podcast discussing legal/value considerations for healthcare service line carveouts
  • 2022
    Co-authored National Law Review article on CMS value-based payment and behavioral health integration policy
  • 2021
    Lead author, National Law Review piece outlining 5 emerging trends in value-based care

Call-prep brief

Background

  • Partner, Healthcare Transactions & Regulatory group, Morgan Lewis (Chicago) since July 2025; previously shareholder at Polsinelli.
  • J.D. Loyola Chicago (2007); early career as law clerk in the Illinois AG's Health Care Bureau, gives her a regulator's-eye view of enforcement priorities.
  • Vice Chair, Academic Medical Centers & Teaching Hospitals Practice Group, American Health Law Association (AHLA).

Current focus

  • Structuring M&A, joint ventures, and clinical integration deals for hospitals, health systems, academic medical centers, and post-acute providers.
  • Regular counsel to PE-backed healthcare platforms and vendors, including physician practice management roll-ups.
  • Active thought leadership on value-based care, service line carveouts, and ACO/CIN governance.

What she cares about

  • Building compliant deal structures (Anti-Kickback/Stark) into the transaction from day one rather than retrofitting compliance post-close.
  • Nonprofit-to-PE transition dynamics, community benefit obligations, charitable trust/AG review, and governance carryover.
  • Service line carveouts and hospital-at-home/telehealth arrangements as emerging platform plays.

Recent moves / sensitivities

  • Fresh lateral (2025), still building her Morgan Lewis book; may be more receptive to new deal-flow relationships but also mindful of non-compete/client-transition obligations from Polsinelli.
  • Confidential client work: her public bio lists engagement *types*, not named clients. Expect her to speak in generalities about past deals absent a signed NDA.

Questions to ask

  1. Which PE-backed provider platforms has she worked with recently on add-on acquisitions, and what deal structures are they gravitating toward in the current rate environment?
  2. What state AG/charitable-trust friction points is she seeing on nonprofit health system divestitures right now?
  3. Where does she see the next wave of service-line carveout or hospital-at-home JV activity, and which health systems are actively shopping?

Outreach draft

Subject
Quick call on healthcare provider platform deals?
Hi Jeanna, Congrats on the move to Morgan Lewis, saw the Chicago healthcare transactions announcement. We're a private equity team focused on pharma services and healthcare provider platforms, and your background structuring hospital/health system JVs and PE-backed provider deals caught our eye, especially your work on compliance-forward deal structuring and service line carveouts. We'd value 20-30 minutes to get your read on current regulatory friction points in provider M&A (Stark/AKS, nonprofit conversions) and where you're seeing deal activity heat up. Happy to work around your schedule this month. Would you be open to a short call? Best, [Placeholder Name]

Linked companies

Sources